WCM Investment Management LLC lessened its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 24.9% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 3,238,109 shares of the company's stock after selling 1,075,962 shares during the period. WCM Investment Management LLC owned approximately 3.18% of DocGo worth $8,549,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Summit Investment Advisors Inc. lifted its holdings in shares of DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares in the last quarter. Prudential Financial Inc. bought a new position in shares of DocGo in the fourth quarter valued at $55,000. Royce & Associates LP bought a new position in shares of DocGo in the fourth quarter valued at $64,000. Boothbay Fund Management LLC grew its holdings in shares of DocGo by 154.9% during the fourth quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company's stock valued at $116,000 after buying an additional 77,445 shares during the last quarter. Finally, ProShare Advisors LLC increased its position in shares of DocGo by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 28,641 shares of the company's stock worth $121,000 after acquiring an additional 9,425 shares in the last quarter. Institutional investors own 56.44% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on DCGO. Needham & Company LLC dropped their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Canaccord Genuity Group reissued a "hold" rating and issued a $1.45 price objective (down from $5.00) on shares of DocGo in a research note on Monday, May 12th. Finally, BTIG Research lowered DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, DocGo has an average rating of "Moderate Buy" and an average price target of $3.56.
Get Our Latest Research Report on DocGo
DocGo Stock Performance
DocGo stock opened at $1.57 on Thursday. DocGo Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $5.68. The firm's 50-day simple moving average is $1.67 and its 200 day simple moving average is $3.03. The stock has a market cap of $160.11 million, a PE ratio of -78.50 and a beta of 0.97.
DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $96.03 million for the quarter, compared to the consensus estimate of $104.25 million. DocGo had a positive return on equity of 2.52% and a negative net margin of 0.12%. As a group, analysts predict that DocGo Inc. will post 0.25 EPS for the current fiscal year.
DocGo Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.